137 related articles for article (PubMed ID: 6470956)
1. Radiotelemetric method for evaluating enteric coatings in vivo.
Dressman JB; Amidon GL
J Pharm Sci; 1984 Jul; 73(7):935-8. PubMed ID: 6470956
[TBL] [Abstract][Full Text] [Related]
2. Accelerating the dissolution of enteric coatings in the upper small intestine: evolution of a novel pH 5.6 bicarbonate buffer system to assess drug release.
Varum FJ; Merchant HA; Goyanes A; Assi P; Zboranová V; Basit AW
Int J Pharm; 2014 Jul; 468(1-2):172-7. PubMed ID: 24727141
[TBL] [Abstract][Full Text] [Related]
3. Application of a radiotelemetric system to evaluate the performance of enteric coated and plain aspirin tablets.
Lui CY; Oberle R; Fleisher D; Amidon GL
J Pharm Sci; 1986 May; 75(5):469-74. PubMed ID: 3735085
[TBL] [Abstract][Full Text] [Related]
4. A paradigm shift in enteric coating: achieving rapid release in the proximal small intestine of man.
Liu F; Basit AW
J Control Release; 2010 Oct; 147(2):242-5. PubMed ID: 20655342
[TBL] [Abstract][Full Text] [Related]
5. Understanding the in vivo performance of enteric coated tablets using an in vitro-in silico-in vivo approach: case example diclofenac.
Kambayashi A; Blume H; Dressman J
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1337-47. PubMed ID: 24056057
[TBL] [Abstract][Full Text] [Related]
6. Towards a Better Understanding of the Post-Gastric Behavior of Enteric-Coated Formulations.
Katona MT; Kakuk M; Szabó R; Tonka-Nagy P; Takács-Novák K; Borbás E
Pharm Res; 2022 Jan; 39(1):201-211. PubMed ID: 35043354
[TBL] [Abstract][Full Text] [Related]
7. Absorption of acetylsalicylic acid from enteric-coated tablets in relation to gastric emptying and in-vivo disintegration.
Bogentoft C; Alpsten M; Ekenved G
J Pharm Pharmacol; 1984 May; 36(5):350-1. PubMed ID: 6145780
[TBL] [Abstract][Full Text] [Related]
8. Dosage form design for improvement of bioavailability of levodopa VI: formulation of effervescent enteric-coated tablets.
Nishimura K; Sasahara K; Arai M; Nitanai T; Ikegami Y; Morioka T; Nakajima E
J Pharm Sci; 1984 Jul; 73(7):942-6. PubMed ID: 6088756
[TBL] [Abstract][Full Text] [Related]
9. Toward Biopredictive Dissolution for Enteric Coated Dosage Forms.
Al-Gousous J; Amidon GL; Langguth P
Mol Pharm; 2016 Jun; 13(6):1927-36. PubMed ID: 27139040
[TBL] [Abstract][Full Text] [Related]
10. A novel coating concept for ileo-colonic drug targeting: proof of concept in humans using scintigraphy.
Varum FJ; Hatton GB; Freire AC; Basit AW
Eur J Pharm Biopharm; 2013 Aug; 84(3):573-7. PubMed ID: 23348235
[TBL] [Abstract][Full Text] [Related]
11. Application of radiotelemetric technique in evaluating diclofenac sodium absorption after oral administration of various dosage forms in healthy volunteers.
Chan KK; Mojaverian P; Ziehmer BA; John VA
Pharm Res; 1990 Oct; 7(10):1026-32. PubMed ID: 2281031
[TBL] [Abstract][Full Text] [Related]
12. Preparation of enteric coated timed-release press-coated tablets and evaluation of their function by in vitro and in vivo tests for colon targeting.
Fukui E; Miyamura N; Uemura K; Kobayashi M
Int J Pharm; 2000 Aug; 204(1-2):7-15. PubMed ID: 11011980
[TBL] [Abstract][Full Text] [Related]
13. In vivo evaluation of enteric-coated naproxen tablets using gamma scintigraphy.
Wilding IR; Hardy JG; Sparrow RA; Davis SS; Daly PB; English JR
Pharm Res; 1992 Nov; 9(11):1436-41. PubMed ID: 1475230
[TBL] [Abstract][Full Text] [Related]
14. Kinetics of release from enteric-coated tablets.
Ozturk SS; Palsson BO; Donohoe B; Dressman JB
Pharm Res; 1988 Sep; 5(9):550-65. PubMed ID: 3247318
[TBL] [Abstract][Full Text] [Related]
15. [Effect of film formers and plasticizers on the stability of resistance and disintegration behavior. 4. Pharmaceutical-technological and analytical studies of gastric juice-resistant commercial preparations].
Thoma K; Heckenmüller H
Pharmazie; 1987 Dec; 42(12):837-41. PubMed ID: 3444846
[TBL] [Abstract][Full Text] [Related]
16. [The solubility kinetics of enteric-resistant tablets using riboflavin test tablets. 6. Pharmaceutic-technologic and analytic studies on gastric juice-resistant dosage forms].
Thoma K; Oschmann R
Pharmazie; 1991 May; 46(5):331-6. PubMed ID: 1896478
[TBL] [Abstract][Full Text] [Related]
17. Evolution of a physiological pH 6.8 bicarbonate buffer system: application to the dissolution testing of enteric coated products.
Liu F; Merchant HA; Kulkarni RP; Alkademi M; Basit AW
Eur J Pharm Biopharm; 2011 May; 78(1):151-7. PubMed ID: 21255647
[TBL] [Abstract][Full Text] [Related]
18. [Resistance and disintegration behavior of gastric juice-resistant drug products. 3. Pharmaceutical-technological and analytical studies of gastric juice-resistant commercial preparations].
Thoma K; Heckenmüller H; Oschmann R
Pharmazie; 1987 Dec; 42(12):832-6. PubMed ID: 3444845
[TBL] [Abstract][Full Text] [Related]
19. Unpredictable Performance of pH-Dependent Coatings Accentuates the Need for Improved Predictive in Vitro Test Systems.
Al-Gousous J; Tsume Y; Fu M; Salem II; Langguth P
Mol Pharm; 2017 Dec; 14(12):4209-4219. PubMed ID: 28199791
[TBL] [Abstract][Full Text] [Related]
20. Dry coating: an innovative enteric coating method using a cellulose derivative.
Obara S; Maruyama N; Nishiyama Y; Kokubo H
Eur J Pharm Biopharm; 1999 Jan; 47(1):51-9. PubMed ID: 10234527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
